Syndax Pharmaceuticals earnings were -$318.8M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest SNDX earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$94.2M, up 11.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNDX reported annual earnings of -$318.8M, with 52.3% growth. The next SNDX earnings date is May 6, 2025.
Syndax Pharmaceuticals Earnings Reports & History FAQ
What were Syndax Pharmaceuticals's earnings last quarter?
On SNDX's earnings call on Invalid Date, Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q4 2024 earnings per share (EPS) of -$1.09, up 7.92% year over year. Total SNDX earnings for the quarter were -$94.17 million. In the same quarter last year, Syndax Pharmaceuticals's earnings per share (EPS) was -$1.01.
The next SNDX earnings call is Invalid Date. Add SNDX to your watchlist to be reminded of Syndax Pharmaceuticals's next earnings date.
What was SNDX's earnings growth in the past year?
As of Syndax Pharmaceuticals's earnings date in Invalid Date, Syndax Pharmaceuticals's earnings has grown year over year. SNDX earnings in the past year totalled -$318.76 million.
Is Syndax Pharmaceuticals profitable or losing money?
As of the last Syndax Pharmaceuticals earnings report, Syndax Pharmaceuticals is currently losing money. Syndax Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$318.76 million, a 52.25% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.